PHARMA HOLDINGS AS

9008 TROMSØ

Finances

Return on Equity

−175,39 %

Current Ratio

6,67

Debt-to-Equity Ratio

0,01

Key figures (NOK)	2022	2021	2020	2019
Revenue	4 644 000	6 618 000	3 384 000	1 355 000
Net Income	−27 057 000	−13 746 000	−6 211 000	−2 697 000
Total Assets	18 047 000	7 077 000	6 514 000	2 160 000
Total Equity	15 427 000	6 180 000	4 926 000	1 137 000

Income (NOK)	2022	2021	2020	2019
Revenue	4 644 000	6 618 000	3 384 000	1 355 000
Expenditure	30 359 000	20 394 000	9 605 000	4 032 000
Operating Profit	−25 715 000	−13 776 000	−6 220 000	−2 677 000
Financial Income	117 000	106 000	51 000	0
Financial Costs	1 459 000	76 000	42 000	20 000
Financial Balance	−1 342 000	30 000	9 000	−20 000
Earnings Before Tax	−27 057 000	−13 746 000	−6 211 000	−2 697 000
Tax	0	0	0	0
Net Income	−27 057 000	−13 746 000	−6 211 000	−2 697 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	1 259 000	1 259 000	1 259 000	1 259 000
Total Current Assets	16 789 000	5 819 000	5 256 000	902 000
Total Assets	18 047 000	7 077 000	6 514 000	2 160 000
Total Retained Equity	−21 448 000	0	0	0
Total Equity	15 427 000	6 180 000	4 926 000	1 137 000
Total Long-Term Debt	102 000	0	0	0
Total Current Debt	2 518 000	897 000	1 588 000	1 023 000
Total Equity and Debt	18 047 000	7 077 000	6 514 000	2 160 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	4 618 000	6 618 000	3 384 000	1 355 000
Other Income	26 000	0	0	0
Revenue	4 644 000	6 618 000	3 384 000	1 355 000
Cost of Goods Sold	0	0	9 000	0
Salary Costs	4 672 000	1 814 000	987 000	0
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	30 359 000	20 394 000	9 605 000	4 032 000
Operating Profit	−25 715 000	−13 776 000	−6 220 000	−2 677 000
Financial Income	117 000	106 000	51 000	0
Financial Costs	1 459 000	76 000	42 000	20 000
Financial Balance	−1 342 000	30 000	9 000	−20 000
Dividends	0	0	0	0
Net Income	−27 057 000	−13 746 000	−6 211 000	−2 697 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	1 259 000	1 259 000	1 259 000	1 259 000
Total Fixed Assets	1 259 000	1 259 000	1 259 000	1 259 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	13 540 000	3 378 000	3 486 000	100 000
Total Current Assets	16 789 000	5 819 000	5 256 000	902 000
Total Assets	18 047 000	7 077 000	6 514 000	2 160 000
Total Equity	15 427 000	6 180 000	4 926 000	1 137 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	102 000	0	0	0
Creditors	1 596 000	528 000	1 307 000	690 000
Unpaid Taxes	188 000	177 000	84 000	0
Dividends	0	0	0	0
Other Current Debt	734 000	191 000	197 000	342 000
Total Current Debt	2 518 000	897 000	1 588 000	1 023 000
Total Equity and Debt	18 047 000	7 077 000	6 514 000	2 160 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−175,39 %	−222,43 %	−126,09 %	−237,2 %
Debt-to-Equity Ratio	0,01	0	0	0
Operating Profit Margin	−553,73 %	−208,16 %	−183,81 %	−197,56 %
Current Ratio	6,67	6,49	3,31	0,88
Quick Ratio	6,67	6,49	3,31	0,88
Equity Ratio	0,85	0,87	0,76	0,53
Gross Profit Margin	100 %	100 %	99,73 %	100 %